Chronic Weight Management
Conditions
Brief summary
Percent change from baseline in body weight at week 72
Detailed description
Change from baseline in waist circumference (cm) at week 72, Achieving ≥5% reduction in body weight from baseline at week 72, Achieving ≥10% reduction in body weight from baseline at week 72, Achieving ≥15% reduction in body weight from baseline at week 72, Achieving ≥20% reduction in body weight from baseline at week 72, Change from baseline in SBP (mmHg) at week 72, Percent change from baseline in fasting triglycerides at week 72, Change from baseline in the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT) Physical Function Composite Score at week 72, Change from baseline in fasting glucose at week 72
Interventions
Sponsors
Amgen Inc.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent change from baseline in body weight at week 72 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline in waist circumference (cm) at week 72, Achieving ≥5% reduction in body weight from baseline at week 72, Achieving ≥10% reduction in body weight from baseline at week 72, Achieving ≥15% reduction in body weight from baseline at week 72, Achieving ≥20% reduction in body weight from baseline at week 72, Change from baseline in SBP (mmHg) at week 72, Percent change from baseline in fasting triglycerides at week 72, Change from baseline in the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT) Physical Function Composite Score at week 72, Change from baseline in fasting glucose at week 72 | — |
Countries
Belgium, Czechia, Denmark, Finland, Germany, Italy, Poland, Spain
Outcome results
None listed